- Home
- POAI vs MGRX Comparison
POAI vs MGRX Comparison
Compare POAI & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- MGRX
- Stock Information
- Founded
- POAI 2002
- MGRX 2021
- Country
- POAI United States
- MGRX United States
- Employees
- POAI N/A
- MGRX N/A
- Industry
- POAI Industrial Specialties
- MGRX Computer Software: Prepackaged Software
- Sector
- POAI Health Care
- MGRX Technology
- Exchange
- POAI Nasdaq
- MGRX Nasdaq
- Market Cap
- POAI 8.9M
- MGRX 8.1M
- IPO Year
- POAI N/A
- MGRX 2023
- Fundamental
- Price
- POAI $1.06
- MGRX $1.81
- Analyst Decision
- POAI Hold
- MGRX
- Analyst Count
- POAI 1
- MGRX 0
- Target Price
- POAI N/A
- MGRX N/A
- AVG Volume (30 Days)
- POAI 313.3K
- MGRX 398.2K
- Earning Date
- POAI 05-13-2025
- MGRX 05-14-2025
- Dividend Yield
- POAI N/A
- MGRX N/A
- EPS Growth
- POAI N/A
- MGRX N/A
- EPS
- POAI N/A
- MGRX N/A
- Revenue
- POAI $1,623,817.00
- MGRX $615,873.00
- Revenue This Year
- POAI $486.27
- MGRX N/A
- Revenue Next Year
- POAI $65.50
- MGRX N/A
- P/E Ratio
- POAI N/A
- MGRX N/A
- Revenue Growth
- POAI N/A
- MGRX N/A
- 52 Week Low
- POAI $0.55
- MGRX $1.49
- 52 Week High
- POAI $3.06
- MGRX $16.80
- Technical
- Relative Strength Index (RSI)
- POAI 47.00
- MGRX 39.29
- Support Level
- POAI $0.85
- MGRX $1.63
- Resistance Level
- POAI $1.44
- MGRX $2.85
- Average True Range (ATR)
- POAI 0.11
- MGRX 0.38
- MACD
- POAI 0.00
- MGRX 0.08
- Stochastic Oscillator
- POAI 42.86
- MGRX 23.38
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.